Hospice CARE Act of 2026
Summary
HR7966 (Hospice CARE Act of 2026) proposes a 5-year nationwide moratorium on new Medicare hospice enrollment, but is in early legislative stages—referred to committee with only 2 cosponsors. No explicit funding, no near-term market impact. No public companies directly affected at this stage.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7966 is an early-stage bill with no funding attached—near-term market impact is zero.
- 2.Only 2 cosponsors, no scheduled markups, and identical companion bill just referred to the Senate Finance Committee.
- 3.Existing hospice providers (no publicly traded pure plays of scale) would retain market positions; no ticker movement warranted.
Market Implications
No current market implications. The bill is procedural noise at this stage. If it advances out of committee, small-cap hospice operators and nursing home REITs with hospice exposure (e.g., $OHI, $WELL) would see minimal structural benefit from reduced new competition. No actionable information now.
Full Analysis
HR7966 was introduced on March 17, 2026, by Rep. Sánchez (D-CA) and referred to the House Committees on Ways and Means and Energy and Commerce. An identical companion bill, S4118, was introduced in the Senate. The bill is in early legislative stages—no hearings, markup, or floor votes scheduled. With only 2 cosponsors and procedural status, near-term passage probability is extremely low. The bill authorizes zero funding; it imposes a regulatory moratorium (a ban on new Medicare hospice provider enrollment for 5 years) with exemptions for underserved areas. No actual dollars are authorized or appropriated. No public companies are explicitly named or directly impacted by this bill at this stage. Hospice care is provided primarily by privately held entities and small regional nonprofits; public companies with hospice exposure (e.g., $CHE, $AMED) are not materially affected because the bill grandfathers existing providers and only halts new enrollment. If the bill advanced, it would structurally benefit existing providers by reducing competition, but at this procedural stage the market impact is negligible. Investors should monitor committee activity; no actionable trade signal currently exists.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To require the Center for Medicare and Medicaid Innovation to test allowing blood transfusions to be paid separately from the Medicare hospice all-inclusive per diem payment.
Concurrent Care for Comfort Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →